-

SK Capital Partners Appoints John Novak as Head of Business Development

NEW YORK--(BUSINESS WIRE)--SK Capital Partners (“SK Capital”), a private investment firm focused on the specialty materials, ingredients, and life sciences sectors, announced today that John Novak has joined the firm as a Managing Director and Head of Business Development. In this position, Mr. Novak will play a leading role in SK Capital’s efforts to identify, prioritize, and execute new investment opportunities across its core sectors, working closely with the firm’s investment teams to support SK Capital’s continued growth.

Mr. Novak brings more than two decades of experience in private equity and investment banking, with a particular focus on building strategic relationships across the industry and sourcing attractive investment opportunities. Prior to joining SK Capital, Mr. Novak was a Managing Director at Paine Schwartz Partners, where he most recently led business development and capital markets efforts with a focus on overseeing and cultivating a pipeline of new investment opportunities. Prior to Paine Schwartz Partners, Mr. Novak held roles at Swander Pace Capital and Banc of America Securities.

“I am excited to join SK Capital as Head of Business Development and look forward to working alongside the firm’s talented team to help drive continued growth and success,” said Mr. Novak.

Mario Toukan, Managing Director at SK Capital Partners, commented, “John has a proven track record of building strong relationships and identifying compelling opportunities that align closely with SK Capital’s investment strategy. His experience, energy, and connectivity make him a valuable addition to the team as we continue to expand our platform and invest in businesses where we can drive transformative growth.”

About SK Capital:
SK Capital is a private investment firm with a disciplined focus on the specialty materials, ingredients, and life sciences sectors. The Firm seeks to build resilient, sustainable, and growing businesses that create substantial long-term value. SK Capital aims to utilize its industry, operating, and investment experience to identify opportunities to transform businesses into higher performing organizations with improved strategic positioning, growth, and profitability, as well as lower operating risk. SK Capital’s portfolio of businesses generates revenues of approximately $12 billion annually, employs more than 25,000 people globally, and operates more than 200 plants in over 30 countries. The Firm currently has approximately $9 billion in assets under management. For more information, please visit www.skcapitalpartners.com.

Contacts

Jeremy Milner
Gregory FCA
jmilner@gregoryfca.com
(401) 862-9422

SK Capital Partners


Release Summary
SK Capital Partners appoints John Novak as Head of Business Development.
Release Versions

Contacts

Jeremy Milner
Gregory FCA
jmilner@gregoryfca.com
(401) 862-9422

More News From SK Capital Partners

Spectrum Vascular Welcomes New Executive Leadership

WHITE PLAINS, N.Y.--(BUSINESS WIRE)--Spectrum Vascular Welcomes New Executive Leadership...

SK Capital Partners Completes the Sale of Florachem to Tradebe Life Sciences

JACKSONVILLE, Fla.--(BUSINESS WIRE)--An affiliate of funds advised by SK Capital Partners, LP (“SK Capital”), a private investment firm focused on the specialty materials, ingredients, and life sciences sectors, announced today that it has completed the sale of Florachem Corporation (“Florachem” or the “Company”) to Tradebe, a global business group dedicated to sustainability. Florachem will join Tradebe’s Life Sciences business line, which is focused on creating a circular economy by purifying...

SK Capital Makes Strategic Investment in Spectrum Vascular

WHITE PLAINS, N.Y.--(BUSINESS WIRE)--SK Capital Makes Strategic Investment in Spectrum Vascular...
Back to Newsroom